The Genetics Core will produce knockout, mutant, and transgenic mice for each of the investigators as described in their project proposals. The Advantages of combining forces in a Core for this activity are obvious since the technical expertise required to manipulate DNA constructs, selected for homologous recombination in ES cells, and produce chimeric mice is considerable. In addition, the cost of running a mouse colony for blastocyst injection are high and the maintenance of specific Cre recombinase expressing lines in a central Core greatly reduces the cost to individual investigator and provides ready access to a valuable resource. The Genetics Core will assist all investigators by providing advice with DNA construction, ES cell culture, electroporation, selection, and screening. The Genetics Core take on the responsibility of training individuals from the participating labs in all aspects of mouse genetics and this training will occur in the Genetics Core laboratory. This hands- on guidance will assure success and encourage investigators to utilize these powerful new approaches to study cardiovascular physiology. Although it might be somewhat more efficient to simply make the mutant mice in the Genetics Core without the participation of project investigators, this was deemed to unlikely to enhance the s the training environment that we are trying to maintain as an academic entity. We expect the graduate student and postdoctoral fellows trained in our Program to be future leaders in the use of mouse genetic approaches to study cardiac function.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL044948-14
Application #
6914217
Study Section
Project Start
2004-07-01
Project End
2006-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
14
Fiscal Year
2004
Total Cost
$102,374
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Kaufmann, Susann G; Westenbroek, Ruth E; Maass, Alexander H et al. (2013) Distribution and function of sodium channel subtypes in human atrial myocardium. J Mol Cell Cardiol 61:133-141
Westenbroek, Ruth E; Bischoff, Sebastian; Fu, Ying et al. (2013) Localization of sodium channel subtypes in mouse ventricular myocytes using quantitative immunocytochemistry. J Mol Cell Cardiol 64:69-78
Marshall, Misty R; Clark 3rd, John Patrick; Westenbroek, Ruth et al. (2011) Functional roles of a C-terminal signaling complex of CaV1 channels and A-kinase anchoring protein 15 in brain neurons. J Biol Chem 286:12627-39
Fu, Ying; Westenbroek, Ruth E; Yu, Frank H et al. (2011) Deletion of the distal C terminus of CaV1.2 channels leads to loss of beta-adrenergic regulation and heart failure in vivo. J Biol Chem 286:12617-26
Reiner, Cindy L; McCullar, Jennifer S; Kow, Rebecca L et al. (2010) RACK1 associates with muscarinic receptors and regulates M(2) receptor trafficking. PLoS One 5:e13517
Brunet, Sylvain; Scheuer, Todd; Catterall, William A (2009) Cooperative regulation of Ca(v)1.2 channels by intracellular Mg(2+), the proximal C-terminal EF-hand, and the distal C-terminal domain. J Gen Physiol 134:81-94
Heikaus, Clemens C; Pandit, Jayvardhan; Klevit, Rachel E (2009) Cyclic nucleotide binding GAF domains from phosphodiesterases: structural and mechanistic insights. Structure 17:1551-1557
Santana, Luis F; Navedo, Manuel F; Amberg, Gregory C et al. (2008) Calcium sparklets in arterial smooth muscle. Clin Exp Pharmacol Physiol 35:1121-6
Martinez, Sergio E; Heikaus, Clemens C; Klevit, Rachel E et al. (2008) The structure of the GAF A domain from phosphodiesterase 6C reveals determinants of cGMP binding, a conserved binding surface, and a large cGMP-dependent conformational change. J Biol Chem 283:25913-9
Nathanson, Neil M (2008) Synthesis, trafficking, and localization of muscarinic acetylcholine receptors. Pharmacol Ther 119:33-43

Showing the most recent 10 out of 104 publications